New tools could predict who responds to GVHD therapy
NCT ID NCT01902576
First seen Nov 01, 2025 · Last updated Jun 12, 2026 · Updated 26 times
Summary
This study involves 383 people with chronic Graft-versus-Host Disease (GVHD), a complication after stem cell transplants. Researchers are creating and testing new ways to measure if treatments are working, like the Chronic GVHD-Activity Index. The goal is to better predict which therapies help which patients, without directly testing a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRAFT VS HOST DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fred Hutchinson Cancer Research Center
Seattle, Washington, 98109, United States
Conditions
Explore the condition pages connected to this study.